Session Details

Speakers, titles, times, and locations of ASGCT presentations

Detailed Program

Wednesday Posters: Other Nonviral Delivery

Session Details

763: In Vivo Gene Editing of Non-Small Cell Lung Tumors Directed by CRISPR/Cas Reduces Tumor Growth and Extends Survival

746: Optimization of Lipid Nanoparticles for Gene Editing of the Liver via Intraduodenal Delivery

756: Multiplex CRISPR/Cas9 Knockout Utilizing Sequential Delivery via Microfluidics Transfection System

751: Ionizable Lipid Selection and Targeted LNP Formulation Development for In Vivo CAR-T Therapy

765: Optimization of Fusogenix Proteolipid Vehicles for Extra-Hepatic Delivery of mRNA

761: Peptide Based Nanoparticle-Platform for Extrahepatic Delivery of Functional mRNAs

752: Bioanalytical Development and In Vitro Characterization of mRNA LNP Formulation for In Vivo CAR-T Therapy

760: Rapid Screening of Exosomal RNA Cargo for Therapeutic Research Applications

757: Machine Learning-Design of mRNA Delivery Vehicles for In Vivo T Cell Therapies

769: Improving Endotoxin Determination in Complex Gene Delivery Systems: Challenges and Novel Workflow Modifications

745: High-Throughput Screening Powers the Discovery of Tissue-Specific Lipid Nanoparticles In Vivo

764: Engineered Ribonucleoproteins (eRNPs) for Non-Viral In Vivo Delivery of Gene Editors to Treat Ophthalmic Disorders

766: Development of In Vitro Transcribed mRNA Therapeutics for Cystic Fibrosis

744: Engineered Virus-Like Particle to Deliver CRISPR-Cas9 Ribonucleoprotein In Vivo with Saturated Efficacy and Minimal Off-Target Effects

758: Designing Programmable Nanotechnologies for In Vivo CAR T Cell Generation

754: Non-Viral Pathways to Precision: Utilizing DNA Minicircles to Deliver Adenine and Cytosine Base Editors in Cancer Cells

767: A Platform Approach for Producing Engineered Extracellular Vesicles

750: Ligand-Conjugated Poly (Beta-Amino Ester) Nanoparticles for Targeted mRNA Delivery to Primary T Cells

747: Development of Self-Assembled Functional RNA Nanoparticle for CRISPR-Cas9 System Delivery

748: A Fiber Based Adsorbent to Address Purification Requirements in the Delivery of mRNA Therapies via Extracellular Vesicles

759: Teaching Old Lipids New Tricks: Engineering LNP Composition for Extrahepatic Delivery of DNA for Lung Cancer Imaging and Treatment

768: Implementing Custom Particle Swarm-Differential Evolution Optimization (PSODE) for GFP Plasmid DNA Transfection in Jurkat and Primary T Cells

749: Novel Immune Tropic LNP-Based mRNA Delivery in Non-Human Primates

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.